Shopping Cart
- Remove All
- Your shopping cart is currently empty
Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor (IC50: 42 ± 3 nM) that can lower glucose in an animal model of type 2 diabetes and demonstrates excellent developability properties.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $76 | In Stock | |
2 mg | $119 | In Stock | |
5 mg | $222 | In Stock | |
10 mg | $372 | In Stock | |
25 mg | $629 | In Stock | |
50 mg | $896 | In Stock | |
1 mL x 10 mM (in DMSO) | $268 | In Stock |
Description | Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor (IC50: 42 ± 3 nM) that can lower glucose in an animal model of type 2 diabetes and demonstrates excellent developability properties. |
Targets&IC50 | ASBT:42 ± 3 nM |
Alias | Iinerixibat, GSK2330672 |
Molecular Weight | 546.68 |
Formula | C28H38N2O7S |
Cas No. | 1345982-69-5 |
Smiles | CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(O)=O)CC(O)=O)c(OC)cc2[C@H](N1)c1ccccc1 |
Relative Density. | 1.218 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 21.5 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.